Exelead Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
200
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Exelead General Information
Description
Developer of liquid injectables for rare diseases or small populations intended to save lives. The company specializes in manufacturing lipid nanoparticles, liposomes and pegylation formulations, allowing clients with pre-clinical development and clinical supply.
Contact Information
Website
www.exeleadbiopharma.com(Operating Subsidiary)
Corporate Office
- 6925 Guion Road
- Indianapolis, IN 46268
- United States
Corporate Office
- 6925 Guion Road
- Indianapolis, IN 46268
- United States
Exelead Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Exelead Comparisons
Industry
Financing
Details
Exelead Competitors (4)
One of Exelead’s 4 competitors is CordenPharma, a Private Equity-Backed company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CordenPharma | Private Equity-Backed | Basel, Switzerland | ||||
| Axcellerate Pharma | Corporate Backed or Acquired | Piscataway, NJ | ||||
| Simtra BioPharma Solutions | Private Equity-Backed | Deerfield, IL | ||||
| Alcami | Private Equity-Backed | Wilmington, NC |
Exelead Signals
Exelead Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Exelead FAQs
-
When was Exelead founded?
Exelead was founded in 2017.
-
Where is Exelead headquartered?
Exelead is headquartered in Indianapolis, IN.
-
What is the size of Exelead?
Exelead has 200 total employees.
-
What industry is Exelead in?
Exelead’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Exelead a private or public company?
Exelead is a Private company.
-
What is the current valuation of Exelead?
The current valuation of Exelead is .
-
What is Exelead’s current revenue?
The current revenue for Exelead is .
-
Who are Exelead’s investors?
Essetifin SpA has invested in Exelead.
-
Who are Exelead’s competitors?
CordenPharma, Axcellerate Pharma, Simtra BioPharma Solutions, and Alcami are competitors of Exelead.
-
When was Exelead acquired?
Exelead was acquired on 23-Feb-2022.
-
Who acquired Exelead?
Exelead was acquired by Merck.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process